Teva Pharma Industries Stock Price History
| TEVA Stock | USD 13.01 0.13 1.01% |
Below is the normalized historical share price chart for Teva Pharma Industries extending back to November 07, 1984. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Teva Pharma stands at 13.01, as last reported on the 25th of April, with the highest price reaching 13.03 and the lowest price hitting 12.78 during the day.
If you're considering investing in Teva Stock, it is important to understand the factors that can impact its price. We consider Teva Pharma not too volatile. Teva Pharma Industries owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0911, which indicates the firm had a 0.0911% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Teva Pharma Industries, which you can use to evaluate the volatility of the company. Please validate Teva Pharma's Risk Adjusted Performance of 0.0923, semi deviation of 1.17, and Coefficient Of Variation of 727.55 to confirm if the risk estimate we provide is consistent with the expected return of 0.16%.
At present, Teva Pharma's Total Stockholder Equity is projected to decrease significantly based on the last few years of reporting. The current year's Other Stockholder Equity is expected to grow to about 24.9 B, whereas Common Stock Shares Outstanding is forecasted to decline to about 777 M. . The current year's Price Earnings To Growth Ratio is expected to grow to 0.45, whereas Price To Sales Ratio is forecasted to decline to 0.70. Teva Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 26th of March 1990 | 200 Day MA 10.7419 | 50 Day MA 13.4748 | Beta 1.062 |
Teva |
Sharpe Ratio = 0.0911
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | TEVA | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.72 actual daily | 15 85% of assets are more volatile |
Expected Return
| 0.16 actual daily | 3 97% of assets have higher returns |
Risk-Adjusted Return
| 0.09 actual daily | 7 93% of assets perform better |
Based on monthly moving average Teva Pharma is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Teva Pharma by adding it to a well-diversified portfolio.
Price Book 1.9863 | Enterprise Value Ebitda 20.8433 | Price Sales 0.9862 | Shares Float 1.1 B | Wall Street Target Price 15.5 |
Teva Pharma Stock Price History Chart
There are several ways to analyze Teva Stock price data. The simplest method is using a basic Teva candlestick price chart, which shows Teva Pharma price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | March 27, 2024 | 14.43 |
| Lowest Price | January 30, 2024 | 11.73 |
Teva Pharma April 25, 2024 Stock Price Synopsis
Various analyses of Teva Pharma's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Teva Stock. It can be used to describe the percentage change in the price of Teva Pharma from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Teva Stock.| Teva Pharma Price Rate Of Daily Change | 1.01 | |
| Teva Pharma Price Action Indicator | 0.17 | |
| Teva Pharma Price Daily Balance Of Power | 0.52 |
Teva Pharma April 25, 2024 Stock Price Analysis
Teva Stock Price History Data
The price series of Teva Pharma for the period between Fri, Jan 26, 2024 and Thu, Apr 25, 2024 has a statistical range of 3.25 with a coefficient of variation of 5.82. The price distribution for the period has arithmetic mean of 13.11. The median price for the last 90 days is 13.23. The company completed stock split (2:1) on 1st of July 2004. Teva Pharma Industries had dividends distributed to its stock-holders on 2017-11-27.| Open | High | Low | Close | Volume | ||
04/25/2024 | 12.94 | 13.03 | 12.78 | 13.01 | ||
| 04/23/2024 | 12.94 | 13.03 | 12.78 | 13.01 | 8,982,070 | |
| 04/22/2024 | 12.94 | 12.98 | 12.69 | 12.88 | 7,945,162 | |
| 04/19/2024 | 12.66 | 13.01 | 12.51 | 12.86 | 10,124,993 | |
| 04/18/2024 | 13.17 | 13.21 | 12.75 | 12.78 | 8,957,295 | |
| 04/17/2024 | 13.24 | 13.29 | 12.99 | 13.18 | 6,571,690 | |
| 04/16/2024 | 13.26 | 13.29 | 13.06 | 13.09 | 8,087,902 | |
| 04/15/2024 | 13.53 | 13.57 | 13.13 | 13.23 | 13,512,264 | |
| 04/12/2024 | 13.70 | 13.70 | 13.07 | 13.30 | 15,238,796 | |
| 04/11/2024 | 13.71 | 13.99 | 13.68 | 13.87 | 9,571,339 | |
| 04/10/2024 | 13.80 | 14.00 | 13.80 | 13.85 | 6,204,142 | |
| 04/09/2024 | 14.10 | 14.14 | 13.75 | 13.97 | 10,204,890 | |
| 04/08/2024 | 14.33 | 14.47 | 14.16 | 14.20 | 6,724,338 | |
| 04/05/2024 | 14.20 | 14.33 | 13.95 | 14.25 | 9,242,724 | |
| 04/04/2024 | 14.01 | 14.23 | 13.90 | 13.93 | 8,246,365 | |
| 04/03/2024 | 13.78 | 14.17 | 13.74 | 14.12 | 8,607,103 | |
| 04/02/2024 | 13.83 | 13.88 | 13.65 | 13.86 | 6,691,662 | |
| 04/01/2024 | 14.18 | 14.18 | 13.86 | 13.91 | 5,683,334 | |
| 03/28/2024 | 14.35 | 14.41 | 13.97 | 14.11 | 10,247,122 | |
| 03/27/2024 | 14.19 | 14.45 | 14.16 | 14.43 | 12,251,894 | |
| 03/26/2024 | 14.06 | 14.23 | 14.00 | 14.14 | 7,542,860 | |
| 03/25/2024 | 13.99 | 14.17 | 13.86 | 14.06 | 8,037,377 | |
| 03/22/2024 | 13.72 | 13.97 | 13.69 | 13.89 | 9,281,520 | |
| 03/21/2024 | 13.52 | 13.80 | 13.47 | 13.75 | 7,924,576 | |
| 03/20/2024 | 13.25 | 13.50 | 13.23 | 13.48 | 3,552,313 | |
| 03/19/2024 | 13.29 | 13.42 | 13.17 | 13.35 | 4,843,414 | |
| 03/18/2024 | 13.45 | 13.51 | 13.30 | 13.32 | 4,159,142 | |
| 03/15/2024 | 13.38 | 13.65 | 13.35 | 13.43 | 6,235,152 | |
| 03/14/2024 | 13.64 | 13.75 | 13.30 | 13.50 | 10,773,847 | |
| 03/13/2024 | 13.50 | 13.77 | 13.48 | 13.65 | 7,104,184 | |
| 03/12/2024 | 13.36 | 13.53 | 13.23 | 13.49 | 7,610,204 | |
| 03/11/2024 | 13.57 | 13.60 | 13.32 | 13.35 | 6,579,868 | |
| 03/08/2024 | 13.69 | 13.93 | 13.56 | 13.62 | 10,115,450 | |
| 03/07/2024 | 13.40 | 13.78 | 13.21 | 13.71 | 12,137,301 | |
| 03/06/2024 | 13.58 | 13.65 | 13.40 | 13.53 | 7,419,810 | |
| 03/05/2024 | 13.48 | 13.79 | 13.36 | 13.54 | 12,058,783 | |
| 03/04/2024 | 13.58 | 13.62 | 13.25 | 13.44 | 14,026,061 | |
| 03/01/2024 | 13.18 | 13.56 | 13.12 | 13.50 | 9,125,080 | |
| 02/29/2024 | 13.20 | 13.21 | 13.01 | 13.15 | 10,546,570 | |
| 02/28/2024 | 13.22 | 13.29 | 13.01 | 13.09 | 8,047,824 | |
| 02/27/2024 | 13.15 | 13.36 | 13.06 | 13.30 | 7,961,715 | |
| 02/26/2024 | 13.51 | 13.53 | 13.11 | 13.29 | 16,815,208 | |
| 02/23/2024 | 13.09 | 13.09 | 12.61 | 12.89 | 12,561,082 | |
| 02/22/2024 | 13.05 | 13.15 | 12.93 | 13.05 | 7,834,490 | |
| 02/21/2024 | 13.27 | 13.32 | 12.86 | 13.00 | 9,344,743 | |
| 02/20/2024 | 13.19 | 13.28 | 13.03 | 13.07 | 11,815,605 | |
| 02/16/2024 | 13.21 | 13.24 | 13.00 | 13.02 | 5,689,955 | |
| 02/15/2024 | 13.20 | 13.35 | 13.07 | 13.20 | 12,420,707 | |
| 02/14/2024 | 13.07 | 13.17 | 12.84 | 13.17 | 7,693,524 | |
| 02/13/2024 | 12.79 | 12.95 | 12.66 | 12.92 | 11,009,807 | |
| 02/12/2024 | 12.49 | 13.02 | 12.43 | 12.91 | 23,059,849 | |
| 02/09/2024 | 12.01 | 12.05 | 11.83 | 12.01 | 6,326,505 | |
| 02/08/2024 | 12.10 | 12.15 | 11.93 | 12.09 | 7,089,066 | |
| 02/07/2024 | 12.31 | 12.43 | 12.13 | 12.14 | 6,834,783 | |
| 02/06/2024 | 12.42 | 12.51 | 12.24 | 12.25 | 9,900,093 | |
| 02/05/2024 | 12.27 | 12.45 | 12.13 | 12.38 | 14,434,338 | |
| 02/02/2024 | 12.42 | 12.43 | 12.03 | 12.28 | 11,918,111 | |
| 02/01/2024 | 12.17 | 12.48 | 12.00 | 12.46 | 16,255,031 | |
| 01/31/2024 | 11.67 | 12.64 | 11.62 | 12.10 | 29,904,992 | |
| 01/30/2024 | 11.82 | 11.82 | 11.48 | 11.73 | 31,652,786 | |
| 01/29/2024 | 11.86 | 11.92 | 11.76 | 11.83 | 9,383,898 |
About Teva Pharma Stock history
Teva Pharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Teva is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Teva Pharma Industries will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Teva Pharma stock prices may prove useful in developing a viable investing in Teva Pharma
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 1.1 B | 777 M | |
| Net Loss | -2.1 B | -2 B |
Teva Pharma Stock Technical Analysis
Teva Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Idea Analyzer Now
Idea AnalyzerAnalyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |
| All Next | Launch Module |
Teva Pharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Teva Pharma's price direction in advance. Along with the technical and fundamental analysis of Teva Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Teva to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0923 | |||
| Jensen Alpha | 0.2419 | |||
| Total Risk Alpha | 0.0127 | |||
| Sortino Ratio | 0.1116 | |||
| Treynor Ratio | (2.81) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Teva Pharma Industries. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Complementary Tools for Teva Stock analysis
When running Teva Pharma's price analysis, check to measure Teva Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Teva Pharma is operating at the current time. Most of Teva Pharma's value examination focuses on studying past and present price action to predict the probability of Teva Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Teva Pharma's price. Additionally, you may evaluate how the addition of Teva Pharma to your portfolios can decrease your overall portfolio volatility.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |
Is Teva Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Teva Pharma. If investors know Teva will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Teva Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.4 | Earnings Share (0.50) | Revenue Per Share 14.161 | Quarterly Revenue Growth 0.148 | Return On Assets 0.0454 |
The market value of Teva Pharma Industries is measured differently than its book value, which is the value of Teva that is recorded on the company's balance sheet. Investors also form their own opinion of Teva Pharma's value that differs from its market value or its book value, called intrinsic value, which is Teva Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Teva Pharma's market value can be influenced by many factors that don't directly affect Teva Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Teva Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Teva Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Teva Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.